Ledger.Open graph →
SEC Form D · filed November 1, 2013

ARISAPH PHARMACEUTICALS INC

Offering
$20.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Peninsula Capital Partners L.L.C · Detroit, MIDirectorKevin Ferro · New York, NYDirectorMario F. Marcon · Santa Monica, CADirectorChristopher Kiritsy · Boston, MAExec · DirectorWilliam Bachovchin · Boston, MAExec · DirectorJoseph Suarez · Boston, MAExecClaude Benedict · Boston, MAExecKevin Ferro · CAMBRIDGE, MADirectorMichael Jaharis · New York, NYDirectorAntonio Gotto · New York, NYDirectorRex Roten · Clearwater, FLDirectorThomas Koestler · New York, NYDirectorSteven Jaharis · Winnetka, ILDirectorMadias Nicolaos · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗